Warren Buffett Owns 2 of the Small Dogs of the Dow: Here's Why You Need to Own All 5

The article argues the Dogs of the Dow strategy can be a safer, income-oriented approach for 2026, citing a still-expensive S&P 500 at 28x trailing earnings and 20.9x forward earnings. It highlights the current Small Dogs names—Verizon (6.10% yield), Chevron (3.67%), Procter & Gamble (2.93%), Merck (2.83%), and Coca-Cola (2.71%)—all rated Buy by major firms. The piece frames these dividend stocks as defensive holdings that may hold up better if volatility rises around the midterm election cycle.

Analysis

The setup is less about a broad "value" call and more about a low-beta income basket reasserting itself if macro volatility rises. The key second-order effect is that these names are not just defensive; they are duration-sensitive substitutes for cash when real rates stop falling, which matters if markets begin to price fewer cuts and more election-related policy noise. In that regime, high free-cash-flow yield plus visible capital return should compress dispersion versus the market even if the broad indices keep grinding higher.

The biggest misread is that these are all the same trade. VZ is a balance-sheet repair story with equity upside limited unless leverage falls faster than expected, while CVX is more of a commodity hedge with optionality on geopolitical supply shocks. PG and KO are the cleanest quality defensives, but their relative performance is most vulnerable if consumer-spend elasticity deteriorates and private-label share gains accelerate; MRK sits in the middle with a more binary pipeline/drug-cliff profile, so it should trade better on catalysts than on the "Dogs" narrative alone.

Contrarian angle: the crowd may be overpaying for the idea that "defensive" automatically means "safe." If the market corrects, the first-order downside in these names is smaller, but the opportunity cost can be large if cyclical leadership rotates away from AI without a recession. That makes the better expression a barbell: own the highest-quality income compounders, but avoid assuming all high-yield dogs deserve equal weight; the weakest balance sheets in the group can become value traps if rates stay elevated and refinancing windows tighten over the next 6-12 months.

From a flows perspective, these stocks can outperform in a shallow drawdown because they are under-owned by momentum capital and can attract incremental demand from yield-oriented allocators. The risk is that this becomes a crowded defensive rotation only after the market has already de-risked, which would cap upside. In that case, the trade works best as a relative-value expression versus high-duration winners rather than as an outright index substitute.

Key Decisions for Investors

• Go long PG/KO basket vs. QQQ on a 3-6 month horizon: favorable if volatility rises and breadth narrows; target 5-8% relative outperformance with limited beta exposure.
• Prefer CVX over VZ in the Dogs cohort for a 6-12 month hold: similar defensive branding, but CVX has better inflation/geopolitical optionality and less refinancing risk; VZ is more vulnerable if rates stay higher for longer.
• Use MRK as a catalyst-driven long on pullbacks into earnings / pipeline headlines: downside should be contained, but upside is event-dependent; buy only if entry offers at least 2:1 reward-to-risk into the next 1-2 quarters.
• Avoid equal-weighting the full Dogs basket; underweight the weakest balance-sheet/lowest-growth names and concentrate in PG, KO, and CVX to reduce value-trap risk over the next 6-12 months.
• If the market sells off on election-related volatility, pair long the defensive basket against a high-duration basket rather than adding outright equity beta; this preserves income while monetizing a rotation into capital preservation.